TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
Home
Press release
Jan 26, 2021 11:58 JST
Source:
Eisai
Eisai Listed as a Global 100 Most Sustainable Corporation for the Fifth Time
TOKYO, Jan 26, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced that it has been listed in the 2021 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai's fifth inclusion on the list. Ranked 16rd, Eisai was the highest ranking company among global pharmaceutical companies. Also, Eisai became the highest ranking Japanese company among the five Japanese companies listed in the Global 100.
The Global 100 evaluates the sustainability of approximately 8,100 of the world's major corporations based on various corporate initiatives in areas such as ESG (environment, society and governance). Since 2005, those companies ranking among the top 100 in the world have been announced each year at the World Economic Forum in Davos week. The Global 100 is based on up to 24 key performance indicators covering clean revenue, financial management, supplier performance, employee management and resource management, with the evaluations carried out based on data publicly disclosed in financial filings, integrated reports, or through other such channels. Eisai received high evaluation particularly on clean revenue and investment*, as well as employee safety and stability.
Eisai's corporate philosophy is to give first thought to patients and their families, and increase the benefits that health care provides as well as address diverse healthcare needs worldwide. Based on this corporate philosophy, Eisai is striving to sustainably enhance corporate value by strengthening its ESG initiatives and increasing non-financial value.
* Sales revenue, R&D cost and investment for products such as medicines which are under equitable pricing strategies and included in the WHO Essentials Medicines Lists or used to treat any of in scope diseases, conditions and pathogens defined by the ATM Index Foundation.
Source: Eisai
Sectors: BioTech
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong
March 02 2021 08:06 JST
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090
February 22 2021 14:40 JST
Eisai Receives Corporate Philanthropy Award for Its Efforts to Realize Human Health Care (hhc) Philosophy
February 22 2021 12:11 JST
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
February 15 2021 10:07 JST
Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea
February 01 2021 08:35 JST
Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
January 12 2021 11:37 JST
Eisai Completes Construction of the 5th Manufacturing Building at Kawashima Industrial Park in Japan
December 18 2020 12:09 JST
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Demonstrated Statistically Significant Improvement in OS, PFS and ORR
December 17 2020 11:47 JST
Eisai: Biogen Files New Drug Application for Aducanumab in Japan
December 11 2020 09:43 JST
Eisai to Present Abstracts on Oncology Products and Pipeline at 43rd Annual San Antonio Breast Cancer Symposium
December 04 2020 11:17 JST
More Press release >>
Latest Press Release
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong
Mar 02, 2021 09:06 JST
Mitsubishi Power Commences Development of World's First Ammonia-fired 40MW Class Gas Turbine System
Mar 01, 2021 18:46 JST
MHI Machine Tool Develops Gear Shaping Machine for High-Precision Small-Module Gears Used in Robots
Mar 01, 2021 18:36 JST
Flying Finn Rovanpera Claims the Championship Lead in the Toyota Yaris WRC
Mar 01, 2021 10:46 JST
BYD to Help Kyoto Reach Japan's 2050 Carbon Neutral Goal
Feb 26, 2021 11:20 JST
Fujitsu and University of Toronto Researchers Develop Quantum-Inspired Technology to Optimize Radiation Treatment Plans for Brain Tumors and Other Diseases
Feb 26, 2021 10:59 JST
DENSO and Yamato Transport Develop D-mobico, Compact Mobile Refrigerator
Feb 25, 2021 19:28 JST
Mazda Production and Sales Results for January 2021
Feb 25, 2021 17:33 JST
Honda Reports Production, Sales and Export Results in January, 2021
Feb 25, 2021 15:27 JST
Toyota's Global Sales and Production Up Year-on-Year in January for Fifth Consecutive Month
Feb 25, 2021 15:12 JST
Chubu Miraiz and MC to Launch New Assisted-Living JV
Feb 24, 2021 14:12 JST
Fujitsu Launches AI-powered Physical Rehabilitation Solution 'HOPE ROMREC' in Japan
Feb 24, 2021 10:39 JST
Toyota Breaks Ground for 'Woven City'
Feb 23, 2021 13:43 JST
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090
Feb 22, 2021 15:40 JST
Eisai Receives Corporate Philanthropy Award for Its Efforts to Realize Human Health Care (hhc) Philosophy
Feb 22, 2021 13:11 JST
Northgate Public Services Becomes NEC Software Solutions UK from July 2021
Feb 22, 2021 12:59 JST
TOYOTA GAZOO Racing heads north in search of further snow success
Feb 19, 2021 18:59 JST
Honda Motor Co., Ltd. Announces New President & CEO
Feb 19, 2021 17:23 JST
MITSUBISHI MOTORS Started Operation of a Rooftop Solar Power System at Its Laemchabang Factory in Thailand
Feb 19, 2021 17:05 JST
Activities Report of Hydrogen Utilization Study Group in Chubu
Feb 19, 2021 14:02 JST
More Latest Release >>